Stock A003000 BUKWANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Bukwang Pharmaceutical Co., Ltd.

Equities

A003000

KR7003000007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
6,350 KRW -0.47% Intraday chart for Bukwang Pharmaceutical Co., Ltd. +3.25% +4.10%
Apr. 01 H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion. CI
Mar. 26 Bukwang Pharmaceutical Shares Surge Following Buyback Program Announcement MT

Business Summary

Bukwang Pharm Co Ltd is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through two segments. The Medicines and Quasi-drugs segment mainly produces and distributes pharmaceutical products including antidiabetic agents, anemic medicines, thyroid parathyroid hormone drugs, antihistamines, epileptic drugs, bronchodilators, stomatitis drugs, anti-malignant tumors, gum nutrition, hepatitis treatments, targeted anticancer agents, and others. The Research and Development segment mainly researches and develops pharmaceutical products.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
102.8 %
196,932 103.2 % 129,486 102.8 % -34.25%
Consolidated Adjustment
-2.8 %
-6,023 -3.2 % -3,557 -2.8 % -40.93%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.9 %
190,707 99.9 % 125,778 99.9 % -34.05%
Overseas
0.1 %
202 0.1 % 150 0.1 % -25.99%

Managers

Managers TitleAgeSince
Hee-Won Yoo CEO
 Chief Executive Officer 59 -
Woo-Hyun Lee CEO
 Chief Executive Officer 56 -
Sang-Hoon Kim PSD
 President 56 -
Won-Tae Park BRD
 Director/Board Member 72 -
Jiyoon Kim SAM
 Sales & Marketing 50 -
Wan-Soo Byun SAM
 Sales & Marketing 60 -
Dong-Yeon Kim PRN
 Corporate Officer/Principal 86 -
Chang-Soo Chung PRN
 Corporate Officer/Principal 87 -

Members of the board

Members of the board TitleAgeSince
Chang-Soo Chung PRN
 Corporate Officer/Principal 87 -
Dong-Yeon Kim PRN
 Corporate Officer/Principal 86 -
Sang-Hoon Kim PSD
 President 56 -
Won-Tae Park BRD
 Director/Board Member 72 -
Sam-Moon Cho BRD
 Director/Board Member 80 -
Hee-Won Yoo CEO
 Chief Executive Officer 59 -
Sang-Yong Kim BRD
 Director/Board Member 59 -
Beom-Soo Kim BRD
 Director/Board Member 61 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 68,454,671 44,966,857 ( 65.69 %) 2,608,378 ( 3.810 %) 65.69 %

Shareholders

NameEquities%Valuation
OCI HOLDINGS COMPANY LTD.
10.90 %
7,747,934 10.90 % 38 M ₩
Dong-Yeon Kim
9.925 %
7,053,266 9.925 % 35 M ₩
Chang-Soo Chung
8.514 %
6,050,000 8.514 % 30 M ₩
BUKWANG PHARMACEUTICAL CO., LTD.
3.671 %
2,608,378 3.671 % 13 M ₩
National Pension Service of Korea
2.445 %
1,737,409 2.445 % 9 M ₩
Sang-Hoon Kim
0.8000 %
568,504 0.8000 % 3 M ₩
KB Asset Management Co. Ltd.
0.0787 %
55,945 0.0787 % 276 764 ₩
Kyobo AXA Investment Managers Co., Ltd.
0.0569 %
40,401 0.0569 % 199 867 ₩
Bukwang Pharmaceutical Co., Ltd. ESOA
0.0406 %
28,846 0.0406 % 142 703 ₩
Sumitomo Mitsui Asset Management Co., Ltd.
0.0185 %
13,118 0.0185 % 64 896 ₩

Holdings

NameEquities%Valuation
BUKWANG PHARMACEUTICAL CO., LTD.
3.67%
 2,608,378 3.67% 12,903,855 $

Company contact information

Bukwang Pharmaceutical Co., Ltd.

7 Sangdo-ro Dongjak-gu

06955, Seoul

+

http://www.bukwang.co.kr
address Bukwang Pharmaceutical Co., Ltd.(A003000)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
BUKWANG PHARMACEUTICAL CO., LTD. Stock Bukwang Pharmaceutical Co., Ltd.
+4.10% 321M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A003000 Stock
  4. Company Bukwang Pharmaceutical Co., Ltd.